Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1548Source: DataRank Database

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 56 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access56 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.36)OA: bronzeTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Fadi Shehadeh ORCID,Evangelia K. Mylona ORCID,Josiah D. Rich ORCID,Marguerite A. Neill,Francine Touzard-Romo ORCID

Live enrichment

PubMed:33038227 PMC:PMC7665324 OpenAlex:https://openalex.org/W3092486724

Regeneron

Grant: R10933-10987-COV-2069

Regeneron

Grant: R10933-10987-COV-2067

Regeneron

Grant: R10933-10987-COV-2066

NIH

Grant: P20GM121344-01A1 COBRE

NIH

Grant: NIH –P01 AI 083214

NIGMS NIH HHS

Grant: P20 GM121344

NIAID NIH HHS

Grant: P01 AI083214

National Institutes of Health

Grant: 5P20GM121344-04

COBRE Center for Antimicrobial Resistance and Therapeutic Discovery

National Institutes of Health

Grant: 5P01AI083214-10

Harvard-wide Program on Antibiotic Resistance

FWCI

1.36

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/article-pdf/73/1/e208/38846967/ciaa1548.pdf

publisherhttps://academic.oup.com/cid/article-pdf/73/1/e208/38846967/ciaa1548.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1548/37554490/ciaa1548.pdf

publisherhttp://academic.oup.com/cid/article-pdf/73/1/e208/38846967/ciaa1548.pdf

journalhttps://doi.org/10.1093/cid/ciaa1548

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-190301 basic medicine0303 health sciences03 medical and health sciencesAgedCOVID-19Cohort StudiesHumansImmunization, PassiveSARS-CoV-2Treatment OutcomeCOVID-19 Serotherapy

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAgedHumansImmunization, PassiveCohort StudiesTreatment Outcome

Keywords

MedicineHazard ratioConfidence intervalInternal medicineRelative riskRate ratioIncidence (geometry)CohortProportional hazards modelMortality rateCohort studyUnivariate analysisMultivariate analysisefficacyConvalescent PlasmaCovid-19Sars-cov-2Microbiology (medical)Immunization, PassiveCohort StudiesInfectious DiseasesTreatment OutcomeHumansOnline Only ArticlesCOVID-19 SerotherapyAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being